215 related articles for article (PubMed ID: 32456803)
1. Vitamin D-mitochondria cross-talk could modulate the signaling pathway involved in hypertension development: a translational integrative overview.
Sanz R; Mazzei L; Santino N; Ingrasia M; Manucha W
Clin Investig Arterioscler; 2020; 32(4):144-155. PubMed ID: 32456803
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D-RAAS Connection: An Integrative Standpoint into Cardiovascular and Neuroinflammatory Disorders.
Giménez VMM; Sanz RL; Marón FJM; Ferder L; Manucha W
Curr Protein Pept Sci; 2020; 21(10):948-954. PubMed ID: 32504501
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and Vitamin D Receptor: New Insights in the Treatment of Hypertension.
Lin L; Zhang L; Li C; Gai Z; Li Y
Curr Protein Pept Sci; 2019; 20(10):984-995. PubMed ID: 31389312
[TBL] [Abstract][Full Text] [Related]
4. Nocturnal diastolic blood pressure decline is associated with higher 25-hydroxyvitamin D level and standing plasma renin activity in a hypertensive population.
Zhang M; Xu X; Liu H; Li H; Zhang J; Gao M
Clin Exp Hypertens; 2017; 39(8):685-690. PubMed ID: 28872358
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and cardiovascular disease.
Garcia VC; Martini LA
Nutrients; 2010 Apr; 2(4):426-37. PubMed ID: 22254031
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D and vitamin D receptor activators in treatment of hypertension and cardiovascular disease.
Franczyk A; Stolarz-Skrzypek K; Wesołowska A; Czarnecka D
Cardiovasc Hematol Disord Drug Targets; 2014; 14(1):34-44. PubMed ID: 24597598
[TBL] [Abstract][Full Text] [Related]
7. Daily and seasonal mitochondrial protection: Unraveling common possible mechanisms involving vitamin D and melatonin.
Mocayar Marón FJ; Ferder L; Reiter RJ; Manucha W
J Steroid Biochem Mol Biol; 2020 May; 199():105595. PubMed ID: 31954766
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Vitamin D in the Treatment of Essential Hypertension.
Legarth C; Grimm D; Wehland M; Bauer J; Krüger M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401665
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D status and arterial hypertension: a systematic review.
Pilz S; Tomaschitz A; Ritz E; Pieber TR
Nat Rev Cardiol; 2009 Oct; 6(10):621-30. PubMed ID: 19687790
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D, arterial hypertension & cerebrovascular disease.
Kienreich K; Grubler M; Tomaschitz A; Schmid J; Verheyen N; Rutters F; Dekker JM; Pilz S
Indian J Med Res; 2013 Apr; 137(4):669-79. PubMed ID: 23703334
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and Cardiovascular Disease, with Emphasis on Hypertension, Atherosclerosis, and Heart Failure.
Latic N; Erben RG
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899880
[TBL] [Abstract][Full Text] [Related]
12. Links between Vitamin D Deficiency and Cardiovascular Diseases.
Mozos I; Marginean O
Biomed Res Int; 2015; 2015():109275. PubMed ID: 26000280
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular benefits of vitamin D.
Dong J; Lau CW; Wong SL; Huang Y
Sheng Li Xue Bao; 2014 Feb; 66(1):30-6. PubMed ID: 24553867
[TBL] [Abstract][Full Text] [Related]
14. Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D.
Carrara D; Bruno RM; Bacca A; Taddei S; Duranti E; Ghiadoni L; Bernini G
J Hypertens; 2016 Nov; 34(11):2199-205. PubMed ID: 27648718
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D and cardiovascular disease: is the evidence solid?
Al Mheid I; Patel RS; Tangpricha V; Quyyumi AA
Eur Heart J; 2013 Dec; 34(48):3691-8. PubMed ID: 23751422
[TBL] [Abstract][Full Text] [Related]
16. The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system.
Ferder M; Inserra F; Manucha W; Ferder L
Am J Physiol Cell Physiol; 2013 Jun; 304(11):C1027-39. PubMed ID: 23364265
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and cardiovascular diseases: Causality.
Wimalawansa SJ
J Steroid Biochem Mol Biol; 2018 Jan; 175():29-43. PubMed ID: 28027913
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.
de Cavanagh EM; Inserra F; Ferder L
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H15-44. PubMed ID: 25934099
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D deficiency aggravates nephrotoxicity, hypertension and dyslipidemia caused by tenofovir: role of oxidative stress and renin-angiotensin system.
Canale D; de Bragança AC; Gonçalves JG; Shimizu MH; Sanches TR; Andrade L; Volpini RA; Seguro AC
PLoS One; 2014; 9(7):e103055. PubMed ID: 25048368
[TBL] [Abstract][Full Text] [Related]
20. Interplay of vitamin D and metabolic syndrome: A review.
Prasad P; Kochhar A
Diabetes Metab Syndr; 2016; 10(2):105-12. PubMed ID: 25813139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
